TY - JOUR
T1 - 2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation
T2 - Executive Summary *
AU - Chao, Tze Fan
AU - Joung, Boyoung
AU - Takahashi, Yoshihide
AU - Lim, Toon Wei
AU - Choi, Eue Keun
AU - Chan, Yi Hsin
AU - Guo, Yutao
AU - Sriratanasathavorn, Charn
AU - Oh, Seil
AU - Okumura, Ken
AU - Lip, Gregory Y.H.
N1 - Publisher Copyright:
© 2021. The Author(s).
PY - 2021/1/1
Y1 - 2021/1/1
N2 - The consensus of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for cardiologists, neurologists, geriatricians, and general practitioners in the Asia-Pacific region. In these years, many important new data regarding stroke prevention in AF were reported. The practice guidelines subcommittee members comprehensively reviewed updated information on stroke prevention in AF, and summarized them in this 2021 focused update of the 2017 consensus guidelines of the APHRS on stroke prevention in AF. We highlighted and focused on several issues, including the importance of the AF Better Care pathway, the advantages of non-vitamin K antagonist oral anticoagulants (NOACs) for Asians, the considerations of use of NOACs for Asian AF patients with single one stroke risk factor beyond gender, the role of lifestyle factors on stroke risk, the use of oral anticoagulants during the coronavirus disease 2019 pandemic, etc. We fully realize that there are gaps, unaddressed questions, and many areas of uncertainty and debate in the current knowledge of AF, and the physician's decision remains the most important factor in the management of AF.
AB - The consensus of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for cardiologists, neurologists, geriatricians, and general practitioners in the Asia-Pacific region. In these years, many important new data regarding stroke prevention in AF were reported. The practice guidelines subcommittee members comprehensively reviewed updated information on stroke prevention in AF, and summarized them in this 2021 focused update of the 2017 consensus guidelines of the APHRS on stroke prevention in AF. We highlighted and focused on several issues, including the importance of the AF Better Care pathway, the advantages of non-vitamin K antagonist oral anticoagulants (NOACs) for Asians, the considerations of use of NOACs for Asian AF patients with single one stroke risk factor beyond gender, the role of lifestyle factors on stroke risk, the use of oral anticoagulants during the coronavirus disease 2019 pandemic, etc. We fully realize that there are gaps, unaddressed questions, and many areas of uncertainty and debate in the current knowledge of AF, and the physician's decision remains the most important factor in the management of AF.
KW - APHRS
KW - atrial fibrillation
KW - consensus guidelines
KW - executive summary
KW - stroke prevention
UR - http://www.scopus.com/inward/record.url?scp=85119591417&partnerID=8YFLogxK
U2 - 10.1055/s-0041-1739411
DO - 10.1055/s-0041-1739411
M3 - 文献综述
C2 - 34773920
AN - SCOPUS:85119591417
SN - 0340-6245
VL - 122
SP - 20
EP - 47
JO - Thrombosis and Haemostasis
JF - Thrombosis and Haemostasis
IS - 1
ER -